Your browser doesn't support javascript.
loading
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling.
Barallobre-Barreiro, Javier; Radovits, Tamás; Fava, Marika; Mayr, Ursula; Lin, Wen-Yu; Ermolaeva, Elizaveta; Martínez-López, Diego; Lindberg, Eric L; Duregotti, Elisa; Daróczi, László; Hasman, Maria; Schmidt, Lukas E; Singh, Bhawana; Lu, Ruifang; Baig, Ferheen; Siedlar, Aleksandra Malgorzata; Cuello, Friederike; Catibog, Norman; Theofilatos, Konstantinos; Shah, Ajay M; Crespo-Leiro, Maria G; Doménech, Nieves; Hübner, Norbert; Merkely, Béla; Mayr, Manuel.
Affiliation
  • Barallobre-Barreiro J; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Radovits T; Heart and Vascular Center, Department of Cardiology, Semmelweis University, Budapest, Hungary (T.R., L.D., B.M.).
  • Fava M; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Mayr U; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Lin WY; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Ermolaeva E; Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan (W.-Y.L.).
  • Martínez-López D; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Lindberg EL; IIS-Fundación Jiménez Díaz-Universidad Autónoma and CIBERCV, Madrid, Spain (D.M.-L.).
  • Duregotti E; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (E.L.L., N.H.).
  • Daróczi L; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Hasman M; Heart and Vascular Center, Department of Cardiology, Semmelweis University, Budapest, Hungary (T.R., L.D., B.M.).
  • Schmidt LE; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Singh B; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Lu R; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Baig F; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Siedlar AM; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Cuello F; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Catibog N; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, German Center for Heart Research (DZHK), Hamburg, Germany (F.C.).
  • Theofilatos K; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Shah AM; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Crespo-Leiro MG; King's BHF Centre of Research Excellence, London, UK (J.B.-B., M.F., U.M., W.-Y.L., E.E., E.D., M.H., L.E.S., B.S., R.L., F.B., A.M.S., N.C., K.T., A.M.S., M.M.).
  • Doménech N; Instituto de Investigación Biomédica de A Coruña (INIBIC)-CIBERCV, Complexo Hospitalario Universitario de A Coruña (CHUAC), Universidade da Coruña, Spain (M.G.C.-L., N.D.).
  • Hübner N; Instituto de Investigación Biomédica de A Coruña (INIBIC)-CIBERCV, Complexo Hospitalario Universitario de A Coruña (CHUAC), Universidade da Coruña, Spain (M.G.C.-L., N.D.).
  • Merkely B; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (E.L.L., N.H.).
  • Mayr M; Charité-Universitätsmedizin, Berlin, Germany (N.H.).
Circulation ; 144(25): 2021-2034, 2021 12 21.
Article in En | MEDLINE | ID: mdl-34806902
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Proteoglycans / Extracellular Matrix / ADAMTS5 Protein / Heart Failure Type of study: Prognostic_studies Limits: Animals / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2021 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Proteoglycans / Extracellular Matrix / ADAMTS5 Protein / Heart Failure Type of study: Prognostic_studies Limits: Animals / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2021 Type: Article